Skip to main content
Loading

Reducing resistance of cancer cells to payloads

22 Sep 2025
ADC Cytotoxic Payload
  •  What resistance mechanisms are we still missing beyond drug export and target mutation?
  •  Can we move beyond the same 3 payload classes—how do we expand the repertoire?
  •  Is dual payload deployment a scalable solution to outsmart resistance?
Industry Expert
Remi-Martin Laberge, Co-founder, CTO - Arda Therapeutics